已收盤 02-06 16:00:00 美东时间
+0.210
+1.28%
Director Richard D. Gebert Reports Sale of Independence Realty Trust Inc. Common Shares Richard D. Gebert, Director, reported a disposal of common shares of Independence Realty Trust Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Techno
02-05 00:51
BRIEF-Independence Realty Trust Announces Tax Treatment Of Dividends In 2025 Jan 23 (Reuters) - Independence Realty Trust Inc IRT.N : INDEPENDENCE REALTY TRUST ANNOUNCES TAX TREATMENT OF DIVIDENDS IN 2025 Source text: ID:nBwccF0lWa Further company coverage: IRT.N (( Reuters.Briefs@thomsonreuters.com
01-24 05:43
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
01-12 14:09
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
UBS analyst Ami Probandt maintains Independence Realty Trust (NYSE:IRT) with a Buy and raises the price target from $19 to $20.
01-09 00:33
Independence Realty Trust (IRT) declares $0.17/share quarterly dividend, in line with previous. Forward yield 4.0% Payable Jan. 23; for shareholders of record Dec. 31; ex-div Dec. 31. See IRT Dividend...
2025-12-16 12:29
Alexandria Real Estate Equities (ARE) stock was the second-biggest percentage decliner on the S&P 500 this week, after the real estate investment trust (REIT) on Wednesday nearly halved its quarterly ...
2025-12-07 02:57
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
2025-12-05 08:35
Colliers Securities analyst Barry Oxford downgrades Independence Realty Trust (NYSE:IRT) from Buy to Neutral and lowers the price target from $20 to $18.5.
2025-12-04 21:09
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
2025-11-26 10:07